Clonal Hematopoiesis: Somatic Mutations in Blood Cells and Atherosclerosis

Pradeep Natarajan1,2,3, Siddhartha Jaiswal4,2,3, Sekar Kathiresan5

  • 1Center for Genomic Medicine and Cardiovascular Research Center, Massachusetts General Hospital, Boston (P.N., S.K.). pnatarajan@mgh.harvard.edu.

Insights

Age is a key factor in atherosclerotic cardiovascular disease. Clonal hematopoiesis, common in older adults, increases risks for both blood cancers and cardiovascular disease.

Area of Science:

  • Cardiovascular Science
  • Hematology
  • Genetics

Background:

  • Age is the primary prognostic factor for atherosclerotic cardiovascular disease (ASCVD).
  • Somatic mutations in blood cells, known as clonal hematopoiesis, are increasingly prevalent with age.
  • Over 10% of adults over 70 are affected by clonal hematopoiesis.

Purpose of the Study:

  • To review literature on clonal hematopoiesis and its association with ASCVD.
  • To examine the causal link between clonal hematopoiesis and atherosclerotic cardiovascular disease.

Main Methods:

  • Review of existing scientific literature.
  • Analysis of exome sequence data.
  • Examination of studies on clonal selection and expansion in hematopoietic stem cells.

Main Results:

  • Clonal hematopoiesis is common in older adults and increases with age.
  • Individuals with clonal hematopoiesis face higher risks of hematologic malignancy.
  • Clonal hematopoiesis is associated with an elevated risk of atherosclerotic cardiovascular disease.

Conclusions:

  • Clonal hematopoiesis is a significant risk factor for atherosclerotic cardiovascular disease.
  • Understanding the mechanisms of clonal expansion in hematopoietic stem cells is crucial.
  • Further research is needed to elucidate the causal relationship between clonal hematopoiesis and ASCVD.

Related Concept Videos

Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
14.9K
Hematopoiesis01:21

Hematopoiesis

The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
9.1K
Mutations01:39

Mutations

Overview
94.6K
Overview of Hematopoiesis01:20

Overview of Hematopoiesis

Hematopoiesis, or blood cell production, is a vital biological process that begins early in embryonic development and continues throughout life. This process generates the various types of cells found in blood, including red blood cells, white blood cells, and platelets from hematopoietic stem cells (HSCs).
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
9.6K
T Cell Activation and Clonal Selection01:22

T Cell Activation and Clonal Selection

T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
16.2K
Somatic to iPS Cell Reprogramming01:29

Somatic to iPS Cell Reprogramming

Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.7K